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CD62L
lo ), and produce IFN-c. However, neither the antigen presenting cells (APC) that activate these CD8
+ T EM cells nor the site of their induction have been fully investigated. Because conventional (c)CD8a
+ DC (a subset of CD11c + DC) are considered the major inducers of CD8 + T cells, in this study we focused primarily on cCD8a
+ DC from livers of mice immunized with Pb c-spz and asked whether the cCD8a + DC might be involved in the activation of CD8 + T EM cells. We demonstrate that multiple exposures of mice to Pb c-spz lead to a progressive and nearly concurrent accumulation in the liver but not the spleen of both the CD11c + NK1.1 2 DC and CD8 + T EM cells. Upon adoptive transfer, liver CD11c
2 DC from Pb c-spz-immunized mice induced protective immunity against sporozoite challenge. Moreover, in an in vitro system, liver cCD8a
+ DC induced naïve CD8 + T cells to express the CD8 + T EM phenotype and to secrete IFN-c. The in vitro induction of functional CD8 + T EM cells by cCD8a + DC was inhibited by anti-MHC class I and anti-IL-12 mAbs. These data suggest that liver cCD8a
+ DC present liver-stage antigens to activate CD8 + T EM cells, the pre-eminent effectors against pre-erythrocytic malaria. These results provide important implications towards a design of anti-malaria vaccines.
Introduction
Dendritic cells (DC) are key conductors in the orchestration of the immune responses to a variety of pathogens [1] . A number of DC subsets have been identified, including conventional (c)CD8a
2 DC and plasmacytoid (p)DC and these appear to perform unique functional activities. For example, cCD8a + DC efficiently cross present cell-associated Ags particularly to CD8 + T cells [2, 3] ; cCD8a 2 DC usually promote the activation of CD4 + T cells [4] ; and pDC tend to respond to viral infections [5] and may be involved in the activation of Treg cells [6] . In addition, the distribution of the DC subsets is unique for lymphoid and non-lymphoid organs [7, 8] and this can lead to an organ-specific response often dictated by the tropism of infectious agents. Owing to their prominent role in directing the immune system, DC have been shown to be indispensable for the induction of protective immune responses to a variety of infections [9] , including malaria that is caused by Plasmodia ssp. infected mosquitoes.
Prime-boost immunizations with radiation-attenuated (c) Plasmodia sporozoites (c-spz) constitutes the most effective method for inducing long-lived, sterile protection against the pre-erythrocytic stages (sporozoite and liver) of both rodent and human malaria [10, 11] . We have reported that Plasmodium berghei (Pb) c-spzinduced protection against liver-stage infection is mediated primarily by intrahepatic IFN-c-producing effector/memory CD44 hi CD45RB lo CD62L lo CD8 + T cells (CD8 + T EM ) [12] . However, the mechanisms of activation of intrahepatic CD8 + T EM cells require further investigation. For example, the identity of the APC that process and present liver-stage Ags for the induction of the CD8 + T EM cells remains to be elucidated. Several studies conducted in the past have revealed a critical role for DC in the induction of anti-Plasmodia protection against pre-erythrocytic stage Ags. It has been demonstrated that DC-depleted mice fail to develop protection following c-spz immunization [13] . Bonemarrow derived dendritic cells pulsed with Pb c-spz or Pb-derived antigen induced antigen-specific CD8 + T cell responses [14] . Similary, adoptive-transfer of DC loaded with Plasmodium yoelii (Py) circumsporozoite (CS) protein peptides into BALB/c mice results in the generation of peptide-specific CD8
+ T cells and reduction of parasitemia following infectious challenge [15] . More recently, it has been shown that DC prime Py CS protein specific TCR Tg CD8 + T cells in the LN draining the site of the mosquito bite, however, the CD8 + T cell effector function following infectious sporozoite challenge occurs in the liver and is DC independent [16] . These and other studies comprise a significant body of work on the roles of splenic [17, 18] and bone marrow-derived DC [19, 20] but comparable studies of liver DC have not been carried out, in part because of the paucity of these cells. Nonetheless, liver DC have been shown to play an important role in liver immunity [21] but their involvement in the induction of protective immunity to the liver stage of malaria remains unknown and, hence, requires investigation. In addition, the relative contributions of the various liver DC subsets also remain to be elucidated. Like infectious spz, Pb c-spz infect hepatocytes but the parasites arrest at the liverstage of development, which leads to the apoptosis of the infected hepatocytes [22] . In contrast, infectious sporozoites do not cause infected hepatocytes to undergo apoptosis and are ineffective in inducing protective CD8 + T cells [23, 24] . Because numerous studies [2, 3, 25, 26] have shown that cCD8a + DC in particular can ingest exogenous cell-associated Ag and cross-present it to CD8 + T cells, it is reasonable to assume, therefore, that c-spz-induced apoptotic hepatocytes are internalized by hepatic DC [22] lo ). Therefore, we propose that cCD8a + DC are involved in the induction of the liver-stage antigen-specific CD8 + T cells, the key effectors against liver-stage malaria.
Results
The numbers of CD11c
2 DC are low in the livers of naïve mice, but increase following prime-boost immunizations with Pb c2spz
Liver CD8
+ T cells are the key effectors in protection induced by Pb c2 spz [27] ; however, neither the cellular/molecular processes leading to the induction of these cells nor the sites where this induction occurs have been thoroughly investigated. For example, it is not fully understood whether DC and/or other APC are involved in the presentation of liver-stage Ags for the activation of CD8 + T cells. Because c-spz enter hepatocytes, where they undergo an aborted development, it is reasonable to assume that Ags responsible for the induction of effector CD8 + T cells are expressed primarily in the liver [28] . Because DC are considered the most efficient professional APC, we presumed, therefore, that liver DC might be excellent APC candidates for presentation of liver-stage Ags to CD8 + T cells. For the initial experiments we used flow cytometry to identify a population of CD11c + NK1.1 2 DC in the liver and the spleen according to the gating strategy shown in Fig. 1A and Fig. 2A 
NK1.1
2 DC were negative for B cell, T cell and macrophage markers (Fig. 1B) .
We next investigated whether repeated immunizations of C57BL/6 mice with Pbc2 spz led to the accumulation/expansion of the CD11c
2 DC populations in the liver. IHMNC were analyzed at baseline (naïve) and after each immunization for the presence of CD11c
2 DC. Consistent with another published study [29] (Fig. 1C, D) . Clearly, a population of CD11c + NK1.1 2 DC that was nearly absent in the livers of naïve mice accumulated during the course of repeated immunizations with Pb c2 spz.
Although hepatocytes serve as the primary venue for preerythrocytic stage development and replication of the mammalian Plasmodia spp, sporozoites also pass through the spleen. To determine whether multiple immunizations with Pb c2 spz might have caused an accumulation of DC in the spleen, we examined splenic cells at the same time points as IHMNC for the presence of CD11c
2 DC. We detected CD11c + NK1.1 2 DC in naïve spleens; however, they did not undergo any significant expansion during repeated immunizations with Pb c2 spz (Fig. 2 B, C + T CM were already present at an elevated level (,10%) in the livers of naïve mice, the only significant expansion was seen after the first immunization when the levels increased to ,40% (p = 0.005) (Fig. 1E) Overall, the percentages of CD8 + T EM cells in the spleens were lower than those in the livers of the Pb c2spz immunized mice and similar to our previously published studies [12, 30] , we observed no significant accumulation of CD8 + T EM cells in the spleens of the mice after repeated immunizations with Pb c2spz. (Fig. 2D, E) . These observations strengthen our hypothesis that the presence of CD11c
2 DC in the liver was coincident with the activation of liver CD8 + T EM and T CM cells after immunization with Pb c2spz.
cCD8a
+ DC numbers are low in the livers of naïve mice but increase following immunization with Pb c-spz
It has been reported that splenic and liver DC represent heterogeneous populations [31, 32] and based on the expression of cell surface markers they are divided into three major subsets: cCD8a + DC and cCD8a 2 DC as well as pDC. Moreover, these + DC have been shown to produce proinflammatory cytokines and prime peptide-specific CD8 + T cells during Salmonella infection [35] . Therefore, we asked whether cCD8a
+ DC were present in the expanded population of CD11c
2 DC that accumulated in the livers of Pb c-spz immunized mice. The CD11c + NK1.1 2 DC were gated as described in Fig. 1A and then evaluated for the presence of CD8a (Fig. 3A) . Cytospin preparations of the purified DC subpopulations were stained with Giemsa and examined by microscopy. cCD8a
+ DC possessed an abundant cytoplasm and displayed the characteristic dendrites whereas cCD8a 2 DC were characterized by an abundant cytoplasm and an irregular surface. Plasmacytoid DC displayed a round, smooth surface and an oval nucleus (Fig. 3B) .
The relative percentages of cCD8a + DC were determined in naïve mice and in Pb c-spz immunized mice 6 days after each successive immunization. As can be seen from Fig. 3C DC following the second and the third immunizations, (Fig. 3D ). Similar trends were observed with respect to total numbers of splenic DCs (Table 2 ). There was no increase in the percentage of cCD8a 2 DC in either the liver or spleen following immunization with Pb c-spz ( Fig. 3E and F) .
To confirm that the liver cCD8a + DC induced following immunization with Pb c-spz were not CD8 + T cells that have lost or down-regulated the CD3 marker, we subjected the purified liver cCD8a + DC (Materials and Methods) to two separate analyses: (1) flow cytometry for both surface and intracellular expression of CD3, CD8b and CD11c and (2) quantitative RT-PCR for the presence of CD8b mRNA. According to the flow cytometry results, liver cCD8a + DC were .97% pure ( Fig. 4A ) and this population was negative for CD8b mRNA when assayed at 1 cell per well. (Fig. 4B ). These observations not only confirm that the cCD8a + DC is a subset of the liver CD11c + NK1.1 2 DC, but they demonstrate a significant accumulation of cCD8a + DC in the livers of Pbc-spz-immunized mice (Fig. 3C ). We also characterized the liver cCD8a
+ DC for the expression of CD205, MHC and costimulatory molecules as they have been shown [36] to be expressed on this subset of DC.We found that indeed cCD8a + DC expressed higher levels of CD205 than CD8a 
CD8
+ T cell population of naïve and immunized mice at day 6 after each immunization. Contour plots and bar graphs are representative of three individual mice per group in three independent experiments. doi:10.1371/journal.pone.0005075.g002 + DC from Pb c-spz-immunized mice to serve as APC for the activation/differentiation of naïve CD8
+ T cells and, by extension, to confirm the involvement of DC in the development of protective immunity. CD11c + NK1.1 2 DC isolated from pooled livers were further enriched by magnetic depletion using a cocktail of mAbs (anti-CD3, -CD19, -F4/80, -NK1.1, -Gr-1). cCD8a + DC and pDC cells within the enriched CD11c + NK1.1 2 DC were each obtained by positive selection whereas the cCD8a 2 DC were obtained by negative selection. The purity of the enriched cCD8a + DC ranged between 94-98% based on CD11c, CD8b, CD3 and NK1.1 expression (Fig. 5A and 6A ). The purity of the cCD8a 2 DC and pDC was also .90%. We co-cultured negatively selected CD8 + T cells from naïve mice with either cCD8a + DC, cCD8a
2 DC or pDC derived from the livers of mice immunized with Pb cspz or mice immunized with Pb c-spz and challenged with infectious sporozoites and analyzed the CD8 + T cells on day 4 of the co-culture for the expression of the CD44 hi CD45RB lo activation phenotype. As is evident from the results in Fig. 5B cCD8a + DC are the major IL-12 producers following challenge of Pb c-spz-immunized mice IL-12 is a key cytokine promoting the activation of CD8 + T cells [37] , therefore, we evaluated the different liver DC subpopulations to assess if the superior APC properties of the cCD8a + DC might be related to a greater capacity for producing IL-12. Levels of IL12p40 were measured in day 4 supernatants from co-cultures of naïve CD8
+ T cells with the three DC subpopulations from fullyimmunized mice (Fig. 5F ) and the results revealed that the cCD8a + DC were the highest (.100 pg/ml), the cCD8a 2 DC were the intermediate (,50 pg/ml) and pDC were the lowest + DC Induce CD8 + (,10 pg/ml) producers of IL-12p40. IL-10 was not detected in any of the culture supernatants (data not shown). It should be pointed out that PCR analysis of cytokine specific mRNA isolated from each DC subset confirmed the ELISA results (data not shown).
We also compared the levels of IL-12p40 and IL-10 in the day-4 supernatants co-cultures of naïve CD8 + T cells with the cCD8a + DC subpopulations from fully-immunized or fully-immunized and challenged or naïve-challenged mice. As shown in Fig. 5G , high levels of IL-12p40 were detected in the culture supernatants with cCD8a + DC from fully-immunized or from fully-immunized and challenged mice. In contrast, IL-12p40 was not detected in the supernatants of co-cultures containing cCD8a
+ DC from naïve-challenged mice. IL-10 was not detected in any of the culture supernatants from any of the groups tested.
Activation of CD8
+ T cells by liver cCD8a + DC from Pb c2spz-immunized mice is MHC class I-and IL-12-dependent Ag-specific activation of CD8 + T cells is mediated via the sine qua non ligation of the TCR by peptide:MHC class I complexes and it also requires secondary signals delivered via co-stimulatory molecules [38] and tertiary signals from cytokines [39] . To test whether this CD8 + T cell activation was mediated by the occupancy of the TCR by MHC:peptide complexes and if it was also dependent upon IL-12, we established parallel co-cultures consisting of liver or spleen cCD8a + DC from mice fully immunized with Pb c-spz and liver or splenic CD8 + T cells from naïve mice in the presence or absence of either anti-MHC class I mAb or anti-IL-12 mAb. After 4 days, the acquisition of the CD44 hi CD45RB lo phenotype by CD8 + T cells was analyzed by The APC activity of the liver cCD8a + DC from Pb c-spz immunized mice was markedly superior to that of the same subpopulation of splenic DC, regardless of the source of naïve CD8 + T cells. Whereas the splenic DC induced approximately 5% of CD8 + T cells to express the CD44 hi CD45RB lo phenotype (Fig. 7A) , the liver DC induced at least 2-3-fold higher percentage of these cells (Fig. 7B) . The same superior APC activity of liver DC was also indicated by the fact that the level of IFN-c was nearly three-fold higher (60 pg/ml vs 20 pg/ml) (Fig. 7D) in the supernatants of co-cultures of CD8 + T cells and liver cCD8a + DC as compared to co-cultures with splenic cCD8a + DC (Fig. 7C) .
IFNc was not detected in the supernatants when cCD8a + DC from either source were cultured alone (Fig.7 C, D) .
The capacity of immune liver cCD8a + DC to induce CD8 + T cells to acquire an activation phenotype and produce IFN-c was reduced by nearly 70% in the presence of anti-MHC class I mAb. Although the inclusion of anti-IL-12 mAb had a somewhat lower inhibitory effect than anti-MHC class I mAb, it also significantly diminished both responses (Fig. 7E and F) . Addition of both blocking antibodies to the co-culture abrogated the activation of CD8 + T cells by reducing both the numbers of CD44 hi CD45RB lo CD8 + T cells and IFN-c production to nearly control levels (response with CD8 + T cells alone), thus suggesting an additive or even synergistic effect of TCR ligation by MHC class I:peptide + DC from Pbc-spz-immunized and challenged mice mediate in vitro activation of naïve CD8 + T cells. HMNC were pooled from livers of Pbc-spz-fully immunized and challenged mice (n = 18) and were incubated with a cocktail of biotinylated microbeads to deplete T cells, B cells, NK cells, granulocytes and macrophages as described in Materials and Methods. DC subpopulations were further isolated from the enriched CD11c + NK1.1 2 population by positive magnetic selection for cCD8a + DC and pDC and by negative selection for CD8a 2 DC, as described in Materials and Methods. (A) Dot plots show the relative % of T cells and NK1.1 cells within the purified cCD8a + DC population. (B) CD8 + T cells were isolated from the spleens of naïve mice using magnetic beads and labeled with 2 mM CFSE. Dot plots show the gating scheme for the analysis of CFSE-labeled CD3 + CD8 Adoptively transferred liver CD11c + NK1.1 2 DC obtained from Pb c2spz-immunized mice confer protection against liver-stage infection It has been reported that adoptive transfer of bone marrowderived DC pulsed with Py CS protein peptide significantly reduces parasitemia in Balb/c mice challenged with Py sporozoites [15] . Based on our preliminary observations that liver CD11c
2 DC from Pb c-spz immunized mice were able to activate CD8 + T cells both in vitro and in vivo (data not shown), we hypothesized that adoptive transfer of these DC into naïve mice might confer protection or at least reduce the level of parasitemia in sporozoite-challenged recipients. In an initial experiment, 1610 6 liver CD11c + NK1.1 2 DC from Pb cspz2immunized mice were adoptively transferred (i.v.) into naïve recipients and this group as well as a control group not receiving any DC were subsequently challenged (i.v.) with 10K infectious Pb sporozoites. The results showed that even though the transferred hepatic CD11c + NK1.1 2 DC significantly decreased parasitemia (Fig. 8A ) and prolonged survival following infectious challenge, they were unable to confer sterile protection. Because 10K infectious sporozoites constitute a very high challenge dose, we asked whether protection could be achieved against a lower challenge dose. Thus, in the next set of experiments CD11c + NK1.1 2 DC from the livers of Pb c-spz immunizedchallenged or naïve-challenged mice were transferred separately into naïve recipients that were subsequently challenged with 250 sporozoites. As shown in Fig. 8B , recipients of hepatic CD11c
2 DC from Pb c-spz-immunized-challenged mice were sterilely protected when challenged with 250 infectious sporozoites. However, protection was lost upon re-challenge at 6 months with 250 infectious sporozoites, implying that sterile protective immunity induced by the transferred CD11c + NK1.1 2 DC was short-lived. Notably, hepatic CD11c + NK1.1 2 DC from naïve-challenged mice did not confer protection even against the low-dose challenge. Collectively, these results strongly support our contention that liver CD11c + NK1.1 2 DC are actively involved in mediating protective immunity induced by Pb c-spz and that their protective function depends upon their capacity to present Ag to liver CD8 + T cells that leads to the induction of effector cells against infectious sporozoites. + DC increased significantly after priming and were maintained following boost immunizations, but declined after challenge with infectious sporozoites. The emergence of liver DC was concurrent with the appearance of hepatic CD8 + T EM cells (CD44 hi CD45RB lo ), that in agreement with our previous findings [12, 30] , accumulate slowly, with the peak response occurring only after the 3 rd immunization. This temporal relationship between the CD11c + NK1.1 2 DC and CD8 + T cells suggests that liver DC serve as key Pb liver-stage Ag-presenting cells that induce liver CD8 + T cells to differentiate into the major effector T cells that confer protection against infectious sporozoite challenge. This contention is further supported by our demonstration that liver cCD8a + DC from either Pb c-spz-immunized or Pb c-spz-immunized-challenged mice induced CD8 + T cells from naïve mice to express the CD44 hi CD45RB lo activation phenotype and to produce IFN-c in an in vitro system. Most importantly, adoptive transfer of purified liver CD11c + NK1.1 2 DC isolated from Pb c-spz immunized donors conferred protective immunity to congenic recipient mice challenged with infectious sporozoites.
Like infectious Plasmodia sporozoites, Pb c-spz also invade hepatocytes but they undergo developmental arrest at the liverstage. The aborted forms of liver-stage parasites are thought to provide a repository of liver-stage Ags needed for the induction and the maintenance of sterile and long lasting protective immunity [28] . However, the mechanisms involved in the processing of these Ags and their presentation to T cells remain to be fully elucidated. Recent studies [22, 40] suggest that infection with either Pb c-spz or genetically-attenuated Plasmodia sporozoites causes hepatocytes to undergo apoptosis, a process that is currently viewed as a potent trigger of host innate and adaptive immune responses [41, 42] . Therefore, it is reasonable to suggest that the attenuated sporozoite-infected apoptotic hepatocytes provide a rich repertoire of liver-stage Ags that are taken up by the liver DC and cross-presented to CD8 + T cells in the liver. Numerous studies [2, 3, 25] have shown that cCD8a + DC are the predominant subpopulation of DC that mediate cross-presentation of cell-associated bacterial and viral Ags for the activation of CD8 + T cells. Data from the present study demonstrate for the first time that cCD8a
+ DC indeed were represented in the hepatic CD11c
2 DC of Pb c-spz-immunized mice. Although nearly absent in the livers of naïve mice, this subset increased significantly after the priming dose of Pb c-spz and it was the most effective APC that induced CD8 + T cells to both acquire the CD44 hi CD45RB lo activation phenotype and to produce IFN-c in .1 2 cells, purified as described in (A) were isolated from Pbc-spzimmunized-challenged mice and from naïve-challenged mice and adoptively transferred into naïve syngeneic recipients (n = 13) that were challenged 7 days later with either 250 (n = 6) or 1000 (n = 7) infectious sporozoites. The protected group (250 sporozoites) were re-challenged 60 days later along with another group of naïve infectivity control mice (n = 3). Pb c-spz-immunized mice (n = 3), used as positive controls, were sterily protected at challenge and re-challenge. Parasitemia and survival were evaluated from day 2 post-challenge. doi:10.1371/journal.pone.0005075.g008
On the basis of these observations, we propose that liver cCD8a + DC cross-present P. berghei liver-stage Ags derived from apoptotic Pb-infected hepatocytes to liver CD8 + T cells. Based on their percentages and numbers, the cCD8a + DC were not the dominant subset in the livers of Pb c-spz immunized or Pb c-spz immunized-challenged mice. Nevertheless, the liver cCD8a + DC exhibited superior APC activity relative to the other two subsets of liver DC and to splenic cCD8a + DC derived from the same animals. The splenic cCD8a
+ DC remained at a steady level (,10%) during the entire prime-boost immunization with Pb c-spz and their capacity to activate CD8 + T cells from naïve mice to express the CD44 hi CD45Rb lo phenotype and to produce IFN-c was 4-fold lower than that of liver cCD8a + DC. This dichotomy between APC activities of liver and spleen cCD8a + DC may be explained by the fact that Pb c-spz primarily invade and undergo a partial development within hepatocytes. Consequently, the availability of liver-stage Ags for cross-presentation would likely be higher in the liver than the spleen. Thus, the site of the induction of CD8 + T cells (liver versus spleen) might be related to the local availability of Ags for presentation to the responding CD8 + T cells. Infectious sporozoites develop into liver merozoites that are released into the blood stream to infect red blood cells and thus, initiate clinical malaria. Challenging naive mice with infectious sporozoites also led to an accumulation of cCD8a + DC in the liver; however the APC activity of these cells was rather ineffective in comparison to that of liver cCD8a
+ DC from Pbc-spz immunized or Pbc-spz immunized and challenged mice. Several mechanisms may be proposed to explain the difference between the two populations of liver cCD8a + DC. First, two recent reports [23, 24] showed that, in contrast to attenuated sporozoites, infectious Pb sporozoites do not induce infected hepatocytes to undergo apoptosis and hence are able to complete their differentiation into liver-stage merozoites that are released into the blood stream without prior alarming or inducing the immune system. Consequently, there is likely a paucity of available early liver stage Ags in mice with active liver stage infection. Secondly, our previous results demonstrated that MHC class I molecules are down-regulated on both Kupffer cells (KC) [43] and liver DC (unpublished data) 24-48 hrs after the challenge of naive mice. The decreased intensity of MHC class I on the surface of KC leads to a diminution in their APC function [43, 44] . The reduction of MHC class I on cCD8a + DC in infected animals (data not shown) also might have reduced their capacity to present liver-stage Ag to CD8 + T cells. Finally, cCD8a
+ DC from livers of naïve challenged mice do not produce detectable levels of IL-12 and this also could have compromised their capacity to activate CD8 + T cells. These results extend the recently published observations that IL-12-producing DC are found only in mice infected with a non-lethal strain of P. yoelii but not in mice infected with the lethal strain [45] . It should also be noted that in contrast to our observations, a recently published study showed that human pDC that produce IFN-a following viral infection also were able to cross-prime CD8 + T cells [46] . DC-mediated differentiation of Ag-specific CD8 + T cells involves the requisite signal 1 delivered through the ligation of the TCR by peptide-MHC class I complexes as well as the necessary provision of co-stimulation (signal 2) and pro-inflammatory cytokines such as IL-12 (signal 3). Although the characterization of Pb liver-stage Ags is in progress, the exact nature of these Ags is currently unknown. Consequently, we were unable to use defined tetramers or transgenic CD8
+ T cells to verify the Pb Ag specificity of the Pb c-spz-immune-CD8 + T cells. However, the Ag-specificity of the responding CD8 + T cells is strongly implied by the observation that IFN-c production and the expression of the CD44 hi CD45RB lo on CD8+ T cells were abrogated by nearly 70% by anti-MHC class I mAb. The importance of this finding is supported by the fact that MHC class I KO mice are not protected by immunization with Pb c-spz when exposed to a high challenge dose [27] . It has also been shown previously [38] that the activation of CD8 + T cells and polarization toward Th1 activity is dependent on IL-12 as it induces T cell expansion and is required for IFN-c production. In the present study, an essential role for IL-12 in the DC-mediated activation of hepatic CD8 + T cells is suggested by the fact that the hepatic cCD8a
+ DC were the main producers of IL-12. Moreover, anti-IL-12 antibody inhibited both the in vitro induced expression of the CD44 hi CD45RB lo activation phenotype on CD8 + T cells and IFN-c production in co-cultures of CD8 + T cells and cCD8a
The additive/synergistic inhibitory activities of the anti-MHC class-I and anti-IL-12 antibodies indicate that both MHC class I:peptide-complexes and IL-12 were required for the activation of the hepatic CD8 + T cells by cCD8a + DC. Our observations are firmly supported by many previous findings demonstrating the importance of IL-12 in protection against malaria liver-stage infection via its ability to directly induce IFN-c production necessary for protection against liver-stage infection [47, 48, 49] .
It is now well accepted that protective immunity induced by attenuated Plasmodia sporozoites is multi-factorial involving antibodies, CD4
+ T cells as well as other lymphocytes, but that the CD8 + T cells are the main effectors against pre-erythrocytic infection. An essential question remains, therefore, whether the activation of liver-stage Ag-specific CD8 + T cells by DC occurs in the liver or in an immune organ, such as the draining celiac LN, after which the effector CD8 + T cells are recruited to the liver. Although our study addressed neither the issue of CD11c + DC that are constitutively present in the livers of naïve mice [50] , nonetheless such discussion is warranted in order to reach a better understanding of the individual immune events and their integration into the overall mechanisms that culminate in protective immunity.
According to evidence from studies of immune responses elicited by model protein Ags, viral and microbial Ags as well as from studies of responses to Plasmodia Ags, three different scenarios can be considered: (1) DC acquire and present parasite Ag to CD8 + T cells in the draining LN and subsequently the CD8 + T cells migrate to the liver; (2) DC acquire parasite Ags in the liver after which they migrate to the LN to activate CD8 + T cells and then both cells migrate back to liver; and (3) CD8 + T cell:DC interactions occur exclusively in the liver, where DC cross-present liver stage Ag to liver CD8 + T cells. According to the first scenario, immature celiac LN DC with enhanced capacity for Ag uptake, encounter Plasmodia Ags, including those associated with sporozoites that are en route to invade the liver. Among the available Ag for uptake by DC, the CS protein might be the primary candidate as it readily sloughs off but is also quickly replaced on sporozoites. Although uptake of other candidate Plasmodia Ags is quite possible, priming of CD8 + T cells specific for Py CS protein has recently been observed in the draining LN after vaccination with Py c-spz [16] . Following Ag uptake, the DC mature and activate LN CD8 + T cells that then migrate to the liver to perform their effector function during infection. Although our observation of the late emergence of CD44 hi CD45RB lo CD8 + T cells in the liver could be accommodated by this scenario, the incompatibility lies with the Ag specificity as liver CD8 + T cells do not recognize peptides from Pb CS protein (Krzych U, unpublished data). Other sporozoite or early liver-stage Ag specificities are possible, but they have not been tested.
cCD8a
+ DC Induce CD8 + According to the second scenario, liver resident immature DC take up liver-stage Ag from the apoptotic hepatocytes invaded by Pb c-spz. The Ag-loaded and matured DC then migrate to the liver draining LN, where they engage in the induction of CD8 + T cells that subsequently migrate to the liver during infection to perform the effector function. In support of this scenario, influenza-specific CD8+T cells that have been activated in the LN perform optimal effector function only in the presence of Agloaded DC in the lung [51] . Although quite attractive, it has been shown that migratory DC do not normally express the CD8a + phenotype [52] and the cCD8a + DC were the major activators of CD8 + T cells in our system. In addition, according to the results from a preliminary study, the draining LN contains a very small proportion of activated CD8 + T cells following i.d. or i.v. immunizations with Pb c-spz.
The third model proposes that cross presentation of the aborted liver-stage Ags by liver DC and the subsequent activation of liver CD8 + T cells occurs uniquely in the liver. The possibility of the local activation of CD8 + T cells by liver-stage Ag is quite attractive for several reasons, but especially because it enables a rapid response in the event of parasite invasion of the liver that occurs within 2 mins following i.v. challenge [53] . Furthermore, although activated CD8
+ T cells home from other regions of the body to the liver where they become eliminated as a way of purging their destructive effector mechanism [54] , there is also evidence from other studies showing that direct activation of naïve CD8 + T cells can indeed occur in the liver [55, 56, 57] . The accumulation of CD11c
2 DC in the liver could be explained on the basis of an inflammatory response, i.e., production of IL-12 by KC shortly after priming with Pb c-spz [43] . Others have also shown that recruitment of DC to the liver is mediated by soluble factors such as MIP-1a and IL-12, possibly released from KC as DC recruitment is absent in KC cell-depleted animals [58] . KC also trap and maintain DC in the liver via selective adhesion involving N-acetylgalactosamine-mediated interactions [59] . The co-presence of cCD8a + DC and CD8 + T cells in the liver and the proximity of liver-stage Ags from the apoptotic Pb c-spz invaded hepatocytes provide all the necessary elements for the initiation of adoptive immune responses in a non-lymphoid organ that is the venue for infection with Plasmodia parasites.
Materials and Methods

Mice
Female C57BL/6 mice (6-8 weeks old) were purchased from The Jackson Laboratory (Bar Harbor, ME) and were housed at the Walter Reed Army Institute of Research (WRAIR) animal facility and handled according to institutional guidelines. All procedures were reviewed and approved by the Animal Care and Use Committee of the institute and were performed in a facility accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International.
Sporozoites, immunizations and parasitemia
Pb sporozoites were isolated from mosquitoes as described previously [12] Sporozoites were attenuated by exposure to 15,000 rad of c-radiation (Cesium-137 source Mark 1 series or Cobalt-60 Model 109; JL Shepard & Associates, San Fernando, CA). As previously described [12, 30] , mice were primed i.v. with 75K Pbc2spz followed by two i.v. boost immunizations of 20K Pbc2spz administered 1 week apart. Control mice were primed and boosted with material from sham dissected mosquitoes that represented an equivalent number of infected mosquitoes. For challenge experiments, mice were infected i.v. with a low dose of either 250 or 1000 infectious sporozoites or a high dose of 10, 000 infectious sporozoites approximately one week after the last boost immunization. Thin blood smears were prepared from individual mice starting on day 2 after the challenge and the percentage of parasitized red blood cells was determined microscopically.
Antibodies
The following mAbs anti-NK1. 1 
Isolation of IHMC
Mice were euthanized by CO 2 inhalation. Livers were exposed and the inferior vena cava was cut for blood outflow. The livers were perfused with 10ml PBS [32] , removed and pressed through a 70 mM nylon cell strainer (BD Labware, Franklin Lakes, NJ) and the liver cell suspension was processed as previously described [12, 30] . Briefly, the liver cells were washed 16 in PBS, resuspended in PBS containing 35% Percoll (Amersham Pharmacia Biotec, Uppsala, Sweden) and centrifuged at 2,000 rpm for 20 min. Erythrocytes in the cell pellet were lysed with RBC lysis buffer (Sigma, St. Louis, MO) and the remaining hepatic mononuclear cells (HMNC) were washed and resuspended in complete RPMI 1640 medium.
Isolation of hepatic CD11c
+ NK1.1 2 DC CD11c + NK1.1 2 cells were isolated as previously described [2] . Briefly, HMNC were incubated with a cocktail of biotinylated (anti-CD3e, CD19, NK1.1, Gr-1, F4/80) mAb for 15 minutes at 4uC. Following washing in buffer (PBS containing 2mM EDTA and 0.5% BSA), the cells were magnetically labeled with antibiotin microbeads for 15 minutes at 4uC. The CD11c + cells were enriched by negative isolation on a MS column (Miltenyi Biotec) according to the manufacturer's instructions. The purity and viability of the enriched CD11c + NK1.1 2 preparation were assessed by flow cytometry and trypan blue exclusion,.and were found to be ,94% and .96% respectively.
Isolation of CD11c
+ NK1.1 2 
DC subpopulations
For isolation of cCD8a + DC or pDC, enriched hepatic CD11c
2 cells were labeled with CD8a (Ly-2) microbeads or CD45R (B220) microbeads and the labeled cells isolated by positive selection on MS columns. For isolation of cCD8a 2 DC, CD11c
2 cells were labeled with a cocktail of CD8a (Ly-2) and CD45R (B220) microbeads and isolated by negative selection on MS columns. The purity of the DC subpopulations was .95% and viability was .97%.
RT-PCR
Total RNA was extracted from purified splenic CD8 + T cells and purified liver CD8a
+
CD11c
+ cells using an RNeasy Plus Mini Kit (Qiagen, Valencia, CA) and treated with DNase. RNA concentration and quality control were determined by UV spectrophotometry and Real-Time SYBR Green/Rox PCR master kit, CD8a (PPM04031A), CD8b1 (PPM04032E) primer mixes, and Applied Biosystems 7500 Fast Real-Time PCR System. The temperature profile was 10 min at 95uC followed by 40 cycles of (95uC, 15 sec; 60uC, 60 sec). Melting curve analysis was performed after qPCR for quality control purposes.
Flow cytometry
For evaluation of T cell activation, four-color staining of HMNC and splenic MNC was performed using a combination of the following mAb: FITC-anti-CD45RB (16A), PE-anti-CD3 (17A2), PerCP-anti-CD8a (53-6.7), and APC-anti-CD44 (IM7). For identification of CD11c 
CD8a
+ cells, the positively isolated cells were stained using a combination of the following mAb: FITC-anti-NK1.1, PE-anti-CD11c, PerCP-anti-CD19, Pacific Blue-anti-CD3e and Pacific Orange-anti-CD8a. Briefly, 2-10610 5 cells were resuspended in cold assay buffer (PBS containing 1% BSA (Sigma) and 0.01% sodium azide) and incubated with anti-FcR 24G2 and 0.5 mg of the relevant mAb at 4uC for 30 min. Cells were washed and resuspended in cold assay buffer. Flow cytometry analyses of T cells and of DC were performed on a FACSCalibur (BD Biosciences) and an LSRII (BD Biosciences) flow cytometer, respectively. Data analysis was performed using FlowJo 8.1.0 software (Tree Star, Inc., Ashland, OR). (clone 28-8-6) were used at 5 mg/ml. Cells and culture supernatants were harvested at day 4 for determination of CD8 + T cell activation and cytokine production, respectively.
In vitro cultures
CFSE labeling
Purified splenic CD8 + T cells were incubated with 2 mM CFSE (Molecular Probes -Invitrogen, Eugene, OR.) for 7 min at room temperature. Cells were washed three times with 10ml complete culture medium. After the final wash, the cells were resuspended in complete culture medium and viability was .98%. 1610 6 CFSElabeled splenic CD8+T cells were co-cultured with 5610 5 purified cCD8a + DC, cCD8a 2 DC and pDC isolated from livers of Pbcspz-immunized-challenged mice in a 1ml volume of complete culture media in a 48-well tissue culture plate for 4 days. Cells were harvested, washed and stained with PE-anti-CD45RB (16A), PerCP-anti-CD3 (17A2), APC-anti-CD44 (IM7) and Pacific Orange-anti-CD8a for evaluation of T cell activation.
Morphology
Freshly purified hepatic cCD8a + DC, cCD8a
2 DC and pDC were cytospun onto glass slides (1 min at 1000rpm) and fixed in methanol for 15 min at room temperature. Slides were stained with Giemsa (Sigma Diagnostics, St Louis, MO) for 20 min and photographed.
IL-10 and IL-12p40 determination
The presence of IL-10 and IL-12p40 were determined using IL-10 and IL-12p40 ELISA kits (BD Biosciences, San Diego, CA) according to the manufacturer's instructions.
IFN-c Determination
IFN-c was determined using an R&D ELISA kit (R&D Systems, Minneapolis, MN) and according to the manufacturer's instructions.
Adoptive transfer
To evaluate the protective effect of hepatic DC against liver-stage infection, purified CD11c
2 DC ( 1610 6 ) from livers of Pb c2spz-immunized mice were transferred (i.v.) into naïve C57BL/6 mice. Seven days after the adoptive transfer, recipient mice were challenged with 250 or 1000 infectious sporozoites. Parasitemia and survival were evaluated from day 2 post-challenge.
Statistical Analysis
Data are presented as the means6SD, and the differences among groups were analyzed by the Mann-Whitney U test using the Graphpad Prism software. A value of p,0.05 was considered significant.
